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Abstract
Background: Cardiovascular risk factors are increasing in most developing countries. To date, however, very little
standardized data has been collected on the primary risk factors across the spectrum of economic development.
Data are particularly sparse from Africa.
Methods: In the Modeling the Epidemiologic Transition Study (METS) we examined population-based samples of
men and women, ages 25–45 of African ancestry in metropolitan Chicago, Kingston, Jamaica, rural Ghana, Cape
Town, South Africa, and the Seychelles. Key measures of cardiovascular disease risk are described.
Results: The risk factor profile varied widely in both total summary estimates of cardiovascular risk and in the
magnitude of component factors. Hypertension ranged from 7% in women from Ghana to 35% in US men. Total
cholesterol was well under 200 mg/dl for all groups, with a mean of 155 mg/dl among men in Ghana, South Africa
and Jamaica. Among women total cholesterol values varied relatively little by country, following between 160 and
178 mg/dl for all 5 groups. Levels of HDL-C were virtually identical in men and women from all study sites. Obesity
ranged from 64% among women in the US to 2% among Ghanaian men, with a roughly corresponding trend in
diabetes. Based on the Framingham risk score a clear trend toward higher total risk in association with socioeconomic
development was observed among men, while among women there was considerable overlap, with the US
participants having only a modestly higher risk score.
Conclusions: These data provide a comprehensive estimate of cardiovascular risk across a range of countries at
differing stages of social and economic development and demonstrate the heterogeneity in the character and degree
of emerging cardiovascular risk. Severe hypercholesterolemia, as characteristic in the US and much of Western Europe
at the onset of the coronary epidemic, is unlikely to be a feature of the cardiovascular risk profile in these countries in
the foreseeable future, suggesting that stroke may remain the dominant cardiovascular event.
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Introduction
The magnitude and rate of change in cardiovascular
disease (CVD) risk among populations has become
increasingly well understood over the last two decades.
The steep, monotonic downward course of both coron-
ary heart disease and stroke observed in most industrial-
ized countries since the 1970’s has resulted in a decline
in mortality rates in countries like Finland and the US
[1]. At the same time, an enormous surge in CVD
mortality has been documented in Russia and other
regions from the former USSR, and CVD risk status is
increasing markedly in China [2, 3].
The transition to industrialized consumer societies has
been invariably accompanied by rising CVD risk and a
key challenge in global health is to prevent a new wave
of the CVD epidemic from engulfing countries undergo-
ing this transition [4]. The investment in large scale data
projects such as the Global Burden of Disease (GBD)
has created an initial – albeit fragmentary -description
of trends in CVD risk in developing countries [5]. While
this new emphasis on temporal trends in CVD has
greatly strengthened the position of those in the public
health community who argue in favor of population-
wide prevention, many important questions remain un-
answered. The vast majority of developing countries lack
both adequate vital records systems to monitor mortality
and representative survey data to assess CVD risk status.
The current level of CVD burden in these countries, and
the projections for future trends, must therefore be
based on local surveys, inferences from other countries in
the region with appropriate data or some other form of
imputation. Of all the regions in the world, sub –Saharan
Africa has by far the weakest public health infrastructure,
and virtually all published estimates of CVD risk are based
on extremely limited empirical data [6, 7].
Paradoxically, the CVD burden of persons of African
descent living in US, and to a lesser extent in the
Caribbean and the UK, has been the subject of
intense scrutiny over the last half century. Black
Americans have approximately 50% higher rates of hyper-
tension, and as a consequence suffer significantly
increased mortality from stroke [8, 9]. On a global scale,
however, the apparent excess hypertension risk seen in
black Americans is an artifact of the comparison to US
whites; in fact, blood pressures in Caribbean blacks are
similar to those among US whites and hypertension rates
in West Africa generally low [10]. While it is now possible
to place the hypertension risk of populations of African
origin within the international context, to our knowledge
no comparative studies of other aspects of CVD risk,
particularly serum lipids, has yet been undertaken. In this
report we describe both serum lipid levels and other key
measures of CVD risk in five populations across the
African diaspora that span the socio-economic spectrum.
Methods
Sampling design and participant recruitment
Twenty-five hundred adults, ages 25–45, were enrolled
in the Modeling the Epidemiologic Transition Study
(METS) between January 2010 and December 2011. A
detailed description of the study protocol and sample
size calculations has been previously published [11]. In
brief, five hundred participants, approximately 50% of
whom are female, were enrolled in each of five study
sites: rural Ghana, peri-urban South Africa, mixed
urban/rural Seychelles, urban Jamaica and metropolitan
Chicago. All participants, with the exception of the
Seychelles, were of African descent. Probability sampling
was not employed to represent urban-rural populations
within each site. However, the sample is diverse in terms
of types of communities and includes rural, peri-urban,
and urban sites. Further, the study sites were selected to
represent a range of body sizes, i.e., the mean (Body
Mass Index) BMI of adults from the study sites vary
from a low of about 24 kg/m2 in rural Nkwantakese
(Ghana) to a high of 31 kg/m2 in suburban Maywood
(USA) [11]. The study sites also represent a broad range
of social and economic development as defined by the
UN Human Development Index (HDI) 2010: i.e., Ghana
as a low HDI country, South Africa as middle, Jamaica
and the Seychelles as high, and the US as a very high
HDI country [12].
Exclusion criteria included individuals with infectious
diseases, including HIV-positive individuals, and preg-
nant or lactating women, as well as persons with condi-
tions preventing normal physical activities, e.g. lower
extremity disability. In Ghana, a simple random sample
was generated for the age-range of the study from the
population census for the rural town of Nkwantakese. In
both Seychelles and South Africa sex- and age-stratified
random samples were generated from their respective
national censuses. In Kingston, Jamaica, districts were
randomly sampled; beginning from a fixed point in each
district (e.g., the north-west corner), and door-to-door
recruitment was then carried out. Similarly, in
Maywood, IL, USA, all city blocks in the community
were randomized and door-to-door recruitment was
conducted.
The protocol for METS was approved by the Institu-
tional Review Board of Loyola University Chicago, IL,
USA; the Committee on Human Research Publication
and Ethics of Kwame Nkrumah University of Science
and Technology, Kumasi, Ghana; the Research Ethics
Committee of the University of Cape Town, South
Africa; The Ministry of Health and Social Development
Public Health Department, Mahé, Republic of Seychelles;
the Ethics Committee of the University of the West
Indies, Kingston, Jamaica; and the Health Sciences Insti-
tutional Review Board of the University of Wisconsin,
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Madison, WI, USA. Written informed consent was
obtained from all participants in the 5 participating
countries.
Measurements
All measurements were made at outpatient clinics
located in the communities. We developed and used
manuals and training workshops for all study personnel
to ensure high quality data. Standardized data collection
forms were used during the data collection process.
Once collected, all data were entered into the same data-
base and data range checks were employed as additional
quality control measures.
Demographic characteristics including education,
employment, and type of labor (manual or not) were
self-reported using standardized questionnaires. Physical
activity was measured using an accelerometer (Actical,
Phillips Respironics, Bend, OR, USA). Smoking status
was self-reported and was defined as smoking cigarettes,
cigars, or pipes regularly (at least one per day) for at
least one year.
Weight (kg) and height (cm) measurements were
made on all participants while wearing light clothing
and no shoes. Weight was measured to the nearest
0.1 kg using the same model standard calibrated balance
at all five sites (Seca 770, Hamburg, Germany). Height
was measured to the nearest 0.1 cm using a stadiometer
(e.g. Invicta Stadiometer, Invicta, London, UK) with the
participant’s head held in the Frankfort plane. Waist
circumference was measured to the nearest 0.1 cm at
the umbilicus and hip at the point of maximum exten-
sion of the buttocks. BMI was calculated as kg/m2.
Body composition was estimated by bioelectrical
impedance analysis (BIA) with the use of a single-
frequency (50 kHz) impedance analyzer (model BIA
101Q; RJL Systems, Clinton Township, MI). A tetrapolar
placement of electrodes was used on the right hand and
foot. Fat-free mass and fat mass were estimated from
measured resistance by using an equation developed and
validated in the METS cohorts [13].
Blood pressure was measured using the protocol of
our ongoing international hypertension studies [14].
Systolic and diastolic blood pressure and pulse were
measured using the Omron Automatic Digital Blood
Pressure Monitor (model HEM-747Ic, Omron Health-
care, Bannockburn, IL, USA). With the antecubital fossa
at heart level, three measurements were made at each of
two time points separated by approximately 60 min for a
total of six measurements.
Biochemical measures
Participants were asked to fast from the evening prior to
the baseline clinic examination (10 to 12 h). Study
personnel were trained and given clear instructions to
draw blood only if the participant had fasted. In the
event of a non-fasting participant, blood was not drawn,
and the participant was asked to fast and return on the
following examination day. Fasting blood samples were
drawn for analysis of blood sugar, total cholesterol (TC),
triglycerides (TG), and HDL-cholesterol (HDCL-C).
LDL-cholesterol (LDL-C) was calculated using the
Friedewald equation (LDL-C = TC- (HDL-C + TG/5)
[15]. The blood samples were processed and plasma or
serum separated within two hours of collection and
stored at -80 °C in the laboratory at each study site. All
assays were conducted at the Zentrum fϋr Labormedizin,
Leiter Klinische Chemie und Hämatologie, St. Gallen,
Switzerland. Serum lipids were all measured using the
endpoint method (DXC analyzer, Beckman Coulter).
Type I Diabetes (referred to as diabetes) was defined as
blood glucose levels ≥140 mg/dl in Ghana or ≥125 mg/dl
in all other sites.
Statistical analyses
Participant characteristics and CVD risk factors were
summarized using means ± standard deviations (SD)
and proportions. CVD risk scores were calculated based
on the Framingham risk equations developed using the
Joint National Committee (JNC-V) categorization of
blood pressure and the National Cholesterol Education
Program (NCEP) categorization of TC and LDL-C [16].
Briefly, β-coefficients from sex-specific Cox proportional
hazards models for selected CVD risk factors, age, blood
pressure, cigarette use, diabetes status, LDL-C (or TC),
and HDL-C, were applied to the corresponding mea-
surements obtained on METS participants. Statistical
analyses was performed using Stata (version 12, College
Station, TX).
Results
A total of 2506 participants were recruited into METS.
Blood samples were analyzed for 94% (n = 2364) of
recruited participants. Participants with missing
blood analysis were excluded from these analyses
(5.7%). The majority of missing data came from
Jamaica (missing among 103 of 500 participants). Ex-
cluded participants (who had missing data) were
similar in age (p-value > 0.05) but more likely to be
males (p-value < 0.001) compared to participants in-
cluded in the analysis.
The descriptive characteristics of the participants, by
site, are presented in Tables 1 and 2. Mean age was simi-
lar across sites and ranged from 33.07 ± 5.98 years
among women in South Africa to 36.50 ± 5.12 years
among men in the Seychelles. Given the focus of the
parent METS study on obesity, large variations in BMI
are observed by site and by sex. BMI was lowest among
Ghanaian men (22.23 ± 2.68 kg/m2) and South African
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men (22.44 ± 4.27 kg/m2) and was highest among
women in the US (34.07 ± 8.83 kg/m2). Similarly,
mean percent body fat was lowest among Ghanaian
men (16.18 ± 5.83%) and highest among US women
(44.57 ± 6.53%). Among both men and women,
Ghanaians were 6 cm shorter than the African
Americans, likely reflecting deficient nutrient intake
before puberty. South African women and men were
likewise 4–6 cm shorter than their US counterparts.
Ghanaian women were the least educated (7.53 ±
4.12 years) while women in the US (13.82 ± 2.61 years)
were the most educated.
Table 1 Male characteristics by site – mean ± SD
Ghana South Africa Jamaica Seychelles United States
Sample size 206 231 153 229 236
Age (y) 34.60 ± 6.73 33.71 ± 5.59 34.03 ± 5.94 36.50 ± 5.12 35.60 ± 6.23
Weight (kg) 63.57 ± 9.13 65.58 ± 13.58 73.15 ± 14.96 80.13 ± 15.98 92.77 ± 24.82
Height (cm) 168.99 ± 6.63 170.87 ± 6.34 176.02 ± 6.68 173.87 ± 6.16 176.57 ± 6.59
Body Mass Index (kg/m2) 22.23 ± 2.68 22.44 ± 4.27 23.58 ± 4.47 26.47 ± 4.92 29.70 ± 7.53
Waist Circumference (cm) 77.04 ± 10.52 80.91 ± 11.47 80.28 ± 12.08 89.40 ± 11.77 97.16 ± 21.50
Hip Circumference (cm) 91.80 ± 10.85 94.59 ± 8.43 95.12 ± 9.28 102.74 ± 9.56 109.21 ± 15.89
Fat-free Mass (kg) 53.02 ± 5.11 50.63 ± 6.26 57.48 ± 6.93 59.64 ± 7.81 63.29 ± 9.71
Fat Mass (kg) 10.72 ± 5.25 14.96 ± 8.33 15.67 ± 9.19 20.75 ± 9.82 29.48 ± 16.56
% Body Fat 16.18 ± 5.83 21.66 ± 6.91 20.13 ± 7.43 24.67 ± 7.45 29.73 ± 9.01
Plasma Glucose (mg/dL) 100.92 ± 11.67 84.99 ± 13.82 95.35 ± 9.12 107.02 ± 37.20 105.79 ± 34.14
Systolic Blood Pressure (mmHg) 118.92 ± 13.06 128.96 ± 17.07 121.53 ± 12.84 122.63 ± 14.52 127.91 ± 14.55
Diastolic Blood pressure (mmHg) 68.50 ± 11.41 79.59 ± 13.11 71.22 ± 11.13 74.95 ± 11.39 81.04 ± 12.11
MVPA* (1-min bouts) 46.9 ± 24.6 55.5 ± 34.6 29.6 ± 23.3 35.9 ± 24.3 33.1 ± 34.7
Education (y) 9.21 ± 3.95 9.52 ± 2.57 10.64 ± 2.17 13.04 ± 2.33 12.73 ± 1.61
Employed, n (%) 180 (98.36%) 211 (92.10%) 199 (92.13%) 209 (98.12%) 190 (84.07%)
Manual Laborer, n (%) 108 (60.00%) 203 (90.63%) 120 (60.91%) 97 (54.49%) 136 (66.67%)
*MPVA moderate vigorous physical activity by accelerometer
Table 2 Female characteristics by site– mean ± SD
Ghana South Africa Jamaica Seychelles United States
Sample size 288 267 244 265 245
Age (y) 34.03 ± 6.63 33.07 ± 5.98 34.72 ± 6.18 35.81 ± 6.04 35.00 ± 6.28
Weight (kg) 63.59 ± 13.12 81.97 ± 22.27 78.54 ± 18.58 72.09 ± 17.25 91.71 ± 24.40
Height (cm) 157.96 ± 5.71 160.15 ± 6.30 163.24 ± 6.58 161.37 ± 6.52 164.00 ± 6.20
Body Mass Index (kg/m2) 25.50 ± 5.20 31.90 ± 8.18 29.49 ± 6.75 27.64 ± 6.23 34.07 ± 8.83
Waist Circumference (cm) 84.20 ± 12.48 96.90 ± 16.44 91.95 ± 13.80 87.91 ± 12.37 101.88 ± 19.56
Hip Circumference (cm) 100.23 ± 13.26 114.15 ± 15.66 107.90 ± 11.62 104.42 ± 12.40 117.05 ± 16.06
Fat-free Mass (kg) 40.80 ± 5.33 45.19 ± 8.01 46.45 ± 7.11 43.92 ± 7.09 49.57 ± 8.58
Fat Mass (kg) 22.79 ± 8.50 36.77 ± 14.85 32.14 ± 12.09 28.17 ± 11.16 42.27 ± 16.36
%Body Fat 34.82 ± 6.07 43.36 ± 6.63 39.71 ± 6.09 37.81 ± 6.72 44.57 ± 6.53
Plasma Glucose (mg/dL) 99.80 ± 12.47 83.06 ± 28.78 90.91 ± 9.24 95.28 ± 17.95 100.56 ± 35.36
Systolic Blood Pressure (mmHg) 110.47 ± 15.17 118.20 ± 18.62 115.25 ± 14.74 112.26 ± 26.54 117.44 ± 16.16
Diastolic Blood pressure (mmHg) 66.18 ± 11.44 76.30 ± 11.78 72.10 ± 11.38 72.70 ± 26.36 79.60 ± 13.21
aMVPA (1-min bouts) 25.9 ± 16.7 22.0 ± 16.3 19.5 ± 15.3 22.9 ± 14.7 15.1 ± 17.7
Education (y) 7.53 ± 4.12 10.05 ± 2.13 10.78 ± 2.02 12.97 ± 2.38 13.82 ± 2.61
Employed (%) 241 (89.59%) 217 (81.89%) 165 (72.05%) 222 (95.28%) 199 (83.61%)
Manual Laborer (%) 231 (89.88%) 207 (89.61%) 130 (68.42%) 47 (25.13%) 65 (29.82%)
aMPVA moderate vigorous physical activity by accelerometer
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Prevalence of CVD risk factors varied markedly by
study site (Fig. 1). Rates of smoking, obesity, hyperten-
sion, and diabetes were all markedly higher among US
men and women (highest HDI), compared to Ghanaian
men and women (lowest HDI). However, rates among
countries with medium HDI did not show a clear pat-
tern. Among men, obesity prevalence ranged from 1.5%
in Ghana to 41% in US. In Ghana, Seychelles, and the
US obesity prevalence was shifted upward by an
additional 10–20% in women compared to men. How-
ever in South Africa and Jamaica a much more promin-
ent sexual dimorphism was observed, with 10-fold
higher rates in South African women than their male
counterparts and 5-fold higher in women than men in
Jamaica. The geographic variation in diabetes was not
consistent with trends in obesity, with much lower rates
observed in South Africa and Jamaica than might be
anticipated, especially among women. Hypertension
prevalence did, however, closely mirror the obesity rates
across sites, with exception of men in South Africa
where high blood pressure was disproportionately
higher.
Total cholesterol levels were substantially lower
among men outside the US (Table 3), and this was
reflected mainly in lower LDL-C. The distribution of
mean HDL-C levels was more complex, however.
Among men HDL-C levels in Ghana, Jamaica and the
Seychelles clustered in the mid-40’s mg/dl; HDL-C
levels were highest in South Africa (57 mg/dl),
followed by the US (50 mg/dl). Among women all the
non-US sites had mean values of 46–48 mg/dl, while
in the US HDL-C approached 52 mg/dl. Triglyceride
levels were highest in the US and Seychelles and
South Africa among men, and the US among women.
There was no apparent inverse relationship between
HDL-C and triglycerides by site, in fact among
women both HDL-C and triglycerides were highest in
the US.
Fig. 1 Prevalence of smoking, obesity, hypertension, and diabetes by Site and Sex
Table 3 Serum Lipids (mg/dl) by site and sex, mean ± SD
N Ghana N South Africa N Jamaica N Seychelles N United States
Men
Cholesterol (mg/dL) 206 154.54 ± 35.29 231 154.94 ± 40.46 153 155.32 ± 32.61 231 175.75 ± 35.69 236 181.75 ± 39.20
Triglyceride (mg/dL) 206 88.15 ± 45.90 230 96.08 ± 62.70 153 70.74 ± 32.16 231 97.58 ± 77.38 236 95.40 ± 57.15
HDL-C (mg/dL) 205 44.67 ± 16.36 230 56.67 ± 19.76 153 47.11 ± 12.62 128 47.39 ± 13.68 235 50.06 ± 14.91
LDL-C (mg/dL) 205 92.16 ± 30.14 228 82.62 ± 31.89 153 94.13 ± 29.70 128 112.66 ± 34.79 235 112.36 ± 34.43
Women
Cholesterol (mg/dL) 288 166.11 ± 34.07 268 159.60 ± 33.22 244 166.96 ± 33.81 265 165.66 ± 34.51 245 178.25 ± 38.67
Triglyceride (mg/dL) 288 77.25 ± 34.86 268 76.18 ± 37.11 244 74.28 ± 38.39 265 64.48 ± 35.70 245 96.95 ± 61.75
HDL-C (mg/dL) 288 47.20 ± 13.17 268 46.22 ± 16.54 244 46.14 ± 11.80 178 47.85 ± 12.16 244 51.71 ± 14.87
LDL-C (mg/dL) 288 103.38 ± 29.38 268 98.12 ± 27.79 244 105.85 ± 28.54 178 109.08 ± 32.88 244 107.28 ± 33.11
HDL-C HDL-cholesterol, LDL-C LDL-cholesterol
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A continuous risk score based on the Framingham
model was used to generate summary estimates of CVD
risk (Fig. 2a, b). Substantial overlap existed for women in
the cross-site comparison, although US women clearly
had a higher risk score distribution. Among men, on the
other hand, more separation of the risk score distributions
was observed, with the rank order, low to high, − Ghana,
Jamaica, Seychelles, South Africa, and finally the US.
Discussion
The data presented in this report depict a heterogeneous
pattern of CVD risk in populations of African origin.
Overall, the prevalence of CVD risk factors are much
lower in Ghana (lowest HDI) compared to the United
States (highest HDI), while in sites with a medium HDI
prevalence’s fall between those observed in Ghana and
the United States. The summary CVD risk, as provided
by the Framingham model, shows a clear trend toward
higher levels in men across the spectrum of economic
development, however in women there is broad over-lap
in the non-US groups. The largest contrasts in preva-
lence rates are seen in obesity and hypertension, ranging
from 2 to 64% for the former and 7 to 35% for the latter.
Diabetes prevalence ranged from less than 1 % in Ghanaian
and Jamaican men to 13% in US women, roughly in parallel
with obesity rates. Data from the GBD study noted high
rates of obesity among children in North Africa and the
Caribbean suggesting a rise in future obesity rates among
these populations [17].
Among two groups the prevalence rates for the CVD
risk factors are not consistent with expectation; for rea-
sons that are unclear Jamaican women had much lower
diabetes rates than would be anticipated on the basis of
the BMI in this study group, and in South Africa men
Fig. 2 CVD risk scores based on the Framingham risk equations among the men (a, N = 1055) and women (b, N = 1309)
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had hypertension rates similar to the US, despite being
lean and active. As is widely recognized, diabetes is
now common in the Caribbean and it is possible that
our recruitment strategy led to a biased sample [18].
We have previously suggested that the hypertension
rates in South African men may reflect psychosocial
pressures and racial discrimination [19]. Our sample is
focused on populations of African origin from different
regions of the world (the US, the Caribbean, and
Africa). Part of the observed heterogeneity could be ex-
plained by the differences in economic development.
CVD risk factors are expected to be higher in more de-
veloped countries that have undergone an epidemio-
logic transition which has been demonstrated using
GBD data [20]. However, the observed heterogeneity in
risk factors could also be explained by regional, cul-
tural, and healthcare system differences, in addition to
differences due to difference levels of economic devel-
opment. For example, smoking rates remain lower in
Ghana compared to the US despite it being more
developed.
LDL-C levels were substantially lower among men
outside the US. In the US, mean LDL-C levels were
similar to those reported by the National Health and
Nutrition Examination Surveys among Non-Hispanic
Black men [21]. Among the serum lipid fractions the
pattern of HDL-C is the most notable finding. By de-
fault, given the rich survey literature, as a standard refer-
ence it is normally expected that men will have HDL-C
levels 10 mg/dl lower than women [22, 23]. Higher
HDL-C in African American men has been well doc-
umented, and a small male: female gradient is ob-
served [24]. It is surprising, however, that HDL levels
were higher in men than women in Jamaica and
South Africa, while being approximately the same
among men compared to women in Ghana, the
Seychelles, and the US (Table 3). These data challenge
the construct that European populations represent the
biological norm. It must be noted, however, that the
marked gender dimorphism in obesity prevalence in
Jamaica and South Africa is likely accounting the
relatively low HDL levels in women from those sites.
Generalizing from this five study samples, it appears
that in populations of African descent sex-specific
HDL levels are similar.
The data presented here confirm the heterogeneity of
CVD risk in Afro-origin populations. As expected,
hypertension is common outside of rural communities.
Obesity is also widespread particularly among women,
and a severe wave of diabetes can be anticipated in the
very near future for all these communities. This has been
reported in the literature for the African region and
projections suggest a 110% absolute increase in the
prevalence of diabetes between 2013 and 2035 [25]. The
evolution of CVD in the period of the peak epidemic
in the US and Europe was driven by high serum chol-
esterol levels and widespread use of tobacco [26]. Our
data suggest that both of those aspects of CVD risk
will not occur in Africa and the Caribbean, certainly
within the coming decades.
A narrow difference in HDL-C between black men and
women in the US compared to whites has long been
noted. These data confirm near equality of HDL-C in both
genders across these populations, with modestly higher
levels in men from Jamaica and especially South Africa.
The gender dimorphism in obesity likely provides an ex-
planation for the finding in South Africa. The consistency
in HDL-C levels across the remaining groups demon-
strates that, contrary to what is observed in European
populations, very little gender-specific effects on HDL-C
are found in groups from sub-Saharan Africa.
The Prospective Urban Rural Epidemiology (PURE)
study is one of the few cohorts comparing CVD risk by
country income group using standardized measures and
complement the results presented in this paper indicat-
ing lower CVD risk in low- and middle- income coun-
tries compared to high- income countries [27].
Our study is one of the few studies examining CVD
risk across multiple sites in Africa, Jamaica, and the
United States. High quality data from African countries
that are comparable with other regions of the world are
scarce [5, 6]. We use standardized questionnaires, proto-
cols, equipment, and lab analysis methodology across
sites making it possible to make these comparisons.
However, we recognize a number of limitations when
interpreting these results. The relative site sample size is
small, and the age range of participants does not include
the elderly who are at greatest risk of CVD. However,
the narrow age range in the study allows for direct com-
parisons across site. Secondly, we present cross-sectional
data and therefore cannot make inference on developing
CVD. To overcome this, we use the Framingham risk
score to estimate future CVD risk, which has been vali-
dated in several populations [28]. Our sampling strategy
was not probabilistic and therefore it is not representa-
tive of the sites in terms of urban and rural locations.
However, we aimed to select sites of broad differences in
socioeconomic development and broad life style
patterns, rather than probability samples representing
the whole population. Finally, despite the training and
use of standardized protocols, it is possible that some
participants did not adhere to the study protocol and
may have not fasted as instructed. This is a limitation to
all population studies.
Conclusions
Our data demonstrate the heterogeneity in the character
and degree of emerging CVD risk among Afro-origin
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populations. This is one of the few studies that uses
standardized data to measure CVD risk factors across
sites in five countries spanning the socio-economic
spectrum. Vital statistics data and measurement of CVD
incidence rates are necessary before the disease burden
can be described in any population. However, the corres-
pondence between risk factors and future events is suffi-
ciently well established to permit a clear prediction of
what the emerging burden in these countries will be.
Coronary heart disease rates are likely to remain low, as
currently is the case in the Caribbean, [29] while stroke
and the ravages of diabetes will be the greatest public
health challenge. This is consistent with results from the
Global Burden of Disease data where CVD deaths
constituted only 8.8% of all deaths and 3.5% of all
disability-adjusted life years (DALYs) in sub-Sahara Af-
rica in 2010 [30]. Early detection and increasing access
to pharmacologic treatment for hypertension could
greatly reduce the burden from stroke. Repeated sample
surveys, using standardized protocols and comparable
data, at intervals of 10 years or less would provide ex-
tremely useful data from which the course of CVD dis-
ease can be predicted, thereby serving as the basis for
policy decisions.
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